GlassScriptPhysician profile
Aron Liaw
NPI 1962760595
$18,023.16
in general payments reported to CMS, 2019-2025
40 companies · $3,250 in 2025
The $3,250 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $185 · 2021: $2,454 · 2022: $5,969 · 2023: $1,173 · 2024: $4,992 · 2025: $3,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,723 · Travel and Lodging: $3,625 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,722.63 |
| Travel and Lodging | $3,624.84 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,432.44 | 2020-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $4,244.16 | 2022 | |
| Coloplast Corp | $3,423.30 | 2021-2025 | |
| Medtronic, INC. | $1,863.00 | 2021-2025 | Altaviva, Interstim |
| Boston Scientific Corporation | $777.62 | 2020-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Procept Biorobotics Corporation | $297.89 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Urogen Pharma, INC. | $252.73 | 2023-2025 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $186.97 | 2023 | Bard Urinary Drainage Bag |
| Ucb, INC. | $181.79 | 2025 | Bimzelx |
| Valencia Technologies Corporation | $174.98 | 2025 | Ecoin Device Kit |
| Mimedx Group, INC. | $172.91 | 2024 | |
| Laborie Medical Technologies Corp. | $157.12 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $156.15 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $155.95 | 2021-2024 | |
| Biotissue Holdings INC. | $140.69 | 2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $133.68 | 2022 | |
| Myriad Genetic Laboratories, INC. | $133.40 | 2022 | |
| Janssen Scientific Affairs, LLC | $117.76 | 2025 | |
| Janssen Biotech, INC. | $113.19 | 2025 | Erleada |
| Abbvie INC. | $112.96 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $106.71 | 2025 | Adstiladrin |
| Antares Pharma, INC. | $100.00 | 2022-2023 | Xyosted, Tlando |
| Smith+Nephew, INC. | $87.98 | 2025 | Grafix, Stravix, Stravix Pl |
| Teleflex LLC | $73.91 | 2022-2025 | Urolift |
| Merck Sharp & Dohme LLC | $52.56 | 2022-2024 | Keytruda, Recarbrio, Dificid |
| Olympus America INC. | $50.90 | 2022 | |
| Dentsply Ih INC. | $45.67 | 2020-2022 | |
| Allergan, INC. | $42.41 | 2021 | |
| Sumitomo Pharma America, INC. | $36.06 | 2023 | Gemtesa |
| Alexion Pharmaceuticals, INC. | $21.98 | 2024 | Strensiq |
| Ethicon US, LLC | $21.32 | 2025 | Stratafix, Vistaseal |
| Convatec INC. | $21.23 | 2023 | |
| Immunitybio, INC. | $21.17 | 2025 | |
| Blue Earth Diagnostics | $20.63 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.92 | 2023 | Oxlumo |
| Endo Pharmaceuticals INC. | $18.63 | 2022 | |
| Astellas Pharma US INC | $17.03 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.25 | 2024 | Xifaxan |
| Tolmar, INC. | $14.09 | 2025 | Eligard, Jatenzo |
| Ambu INC. | $8.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aron Liaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.